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Abstract
Background: Hospital boards have statutory responsibility for upholding the quality of care in their organisations. 
International research on quality in hospitals resulted in a research-based guide to help senior hospital leaders develop and 
implement quality improvement (QI) strategies, the QUASER Guide. Previous research has established a link between board 
practices and quality of care; however, to our knowledge, no board-level intervention has been evaluated in relation to its costs 
and consequences. The aim of this research was to evaluate these impacts when the QUASER Guide was implemented in an 
organisational development intervention (iQUASER). 
Methods: We conducted a ‘before and after’ cost-consequences analysis (CCA), as part of a mixed methods evaluation. The 
analysis combined qualitative data collected from 66 interviews, 60 hours of board meeting observations and documents from 
15 healthcare organisations, of which 6 took part on iQUASER, and included direct and opportunity costs associated with the 
intervention. The consequences focused on the development of an organisation-wide QI strategy, progress on addressing 8 
dimensions of QI (the QUASER challenges), how organisations compared to benchmarks, engagement with the intervention 
and progress in the implementation of a QI project.
Results: We found that participating organisations made greater progress in developing an organisation-wide QI strategy 
and became more similar to the high-performing benchmark than the comparators. However, progress in addressing all 8 
QUASER challenges was only observed in one organisation. Stronger engagement with the intervention was associated with the 
implementation of a QI project. On average, iQUASER costed £23 496 per participating organisation, of which approximately 
44% were staff time costs. Organisations that engaged less with the intervention had lower than average costs (£21 267 per 
organisation), but also failed to implement an organisation-wide QI project.
Conclusion: We found a positive association between level of engagement with the intervention, development of an 
organisation-wide QI strategy and the implementation of an organisation-wide QI project. Support from the board, particularly 
the chair and chief executive, for participation in the intervention, is important for organisations to accrue most benefit. A 
board-level intervention for QI, such as iQUASER, is relatively inexpensive as a proportion of an organisation’s budget.
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Implications for policy makers
• Board-level quality improvement (QI) interventions like iQUASER may be effective for the development of an organisation-wide QI strategy.
• Support from the chair and chief executive and board more widely is important for organisations to accrue most benefit from board-level QI 
interventions.
• Compared to other QI initiatives, a board-level intervention for QI, such as iQUASER, is relatively inexpensive as a proportion of an organisation’s 
budget.
Implications for the public
Several healthcare organisations take some form of action to improve quality for patients in their care. Quality improvement (QI) initiatives can range 
from specific focused small projects to bigger endeavours that involve several layers of management in the organisation. iQUASER was a board-
level QI intervention to help senior hospital leaders develop and implement QI strategies. We have found organisations who took part in iQUASER 
made greater progress in developing an organisation-wide QI strategy and became more similar to the high-performing benchmark. We also found 
that stronger engagement with the intervention was associated with the implementation of a QI project. On average, iQUASER costed £23 496 per 
participating organisation, which is relatively inexpensive as a proportion of their budget. 
Key Messages 
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Background
The Francis inquiry into serious failings of care at Mid 
Staffordshire National Health Service (NHS) Trust highlighted 
the need for hospitals and other healthcare organisations 
to have quality improvement (QI) strategies.1 As a result, 
national level regulators are increasingly concerned with 
supporting the boards of healthcare organisations to devise 
strategies for QI.2 In England, healthcare organisations may 
incorporate more than one hospital, overseen by a single 
corporate board and are characterised by type of service 
provided (acute, community or mental health), foundation 
trust status[1], performance status (as assessed by the English 
healthcare regulator) and number and location of sites.
Previous research has shown that the boards of healthcare 
organisations have an important role in leading and 
overseeing quality and safety.6,7 However, there are few studies 
of board-level interventions, their impact, or associated costs. 
In this paper, we report the costs and consequences from 
an evaluation of a board-level organisational development 
intervention (iQUASER). 
The intervention was based on a guide to assist senior 
hospital leaders to develop an organization-wide QI strategy. 
This guide was based on findings from the QUASER study, 
a collaboration between 5 European countries (England, 
Norway, Sweden, the Netherlands, Portugal) funded by the 
European Union FP7 programme.8 For the intervention, 
Foresight Partnership (FP) (an organizational development 
consultancy now part of GE Healthcare) facilitated the use 
of the guide in 6 NHS healthcare organisations between July 
2014 and May 2015. We studied the impact of this intervention 
using a mixed-method approach, which included a cost-
consequences analysis (CCA), which computes incremental 
costs and compares it to some of the consequences of the 
intervention. We also carried out an in-depth qualitative 
process evaluation, which we have reported elsewhere.9 In the 
present paper, we report findings from the cost-consequence 
analysis.
The QUASER Guide
The QUASER Guide (https://www.eur.nl/sites/corporate/
files/QUASER-GuideForHospitals_0) was designed to help 
senior leaders (boards) of healthcare organisations, wherever 
they are on the ‘quality journey,’10 as a dialogical tool,11 to 
reflect on, develop, and implement organisation-wide QI 
strategies. It was based on detailed research conducted in 
hospitals in 5 European countries during the period April 
2011-March 2012 and included consideration of the national 
healthcare context in each of the participating countries. In 
total, 387 interviews and 796 hours of observation (including 
of 176 meetings relating to QI) were undertaken.8
The guide is structured around 8 interlinked challenges 
for QI, as shown in Figure 1. These are: Leadership, Political, 
Cultural, Educational, Emotional, Physical and Technological, 
Structural, and External Demands. Drawing from the 
QUASER research findings, the guide also provides some 
suggested strategies for how healthcare organisations could 
better deliver high quality and safe services. It then provides 
examples from hospitals that have already implemented these 
strategies elsewhere in Europe.
The iQUASER “intervention”
The aim of the intervention was to use the QUASER Guide 
to help senior leaders (boards) of organisations develop their 
organisation-wide QI strategies. A full list of senior leaders who 
took part on the intervention is available in Supplementary 
file 1. The intervention was developed and delivered by an 
organisational development consultancy, FP, based on the 
dialogical principles of the guide. Each healthcare organisation 
paid a fee of £5000 to participate in the iQUASER intervention. 
They were also offered a tailored and intensive consultancy 
service at a higher fee, but all organisations chose the lower 
cost option. The intervention consisted of 4 phases over a 
10-month period (July 2014-April 2015). The intervention 
has been described in detail in Supplementary file 2, but in 
short Phase 1 consisted of the sign up and introduction to the 
programme, which was presented at a Board Meeting. Phase 2 
involved the completion of an organisational self-assessment 
tool based on the QUASER Guide’s 8 challenges. Participants 
(board members) completed an online questionnaire to assess 
how their organisation had addressed each of the 8 QUASER 
challenges. From the results of the self-completed assessment 
tool, FP generated a report for each healthcare organisation 
to discuss and build a shared view of the key QI challenges 
for each organisation; each organisation was also asked to 
identify one specific organisation-wide QI project. Phase 3 
comprised a workshop attended by senior leaders from the 
participating organisations. The objective of the workshop 
was to explore and develop approaches to implementing an 
organisation-wide QI strategy. Participants were encouraged 
to have arrived at specific goals or commitments to take their 
QI strategy forward. Finally, phase 4 consisted of 3 follow-up 
facilitated action learning sets, which explored implementation 
challenges, and ways to overcome them, as well as following 
up on progress on development of the organisation-wide QI 
strategy and the one selected organisation-wide QI project. 
In addition, in the final learning set participants were asked 
Figure 1. Eight Challenges Highlighted in the QUASER Guide.
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to reflect on the value of the guide in facilitating QI, as well as 
the value of facilitated support for implementation. 
Methods
Study Design
The evaluation of the iQUASER intervention comprised a 
mixed-methods ‘before and after’ study with 2 elements, 
an in-depth qualitative process evaluation and a CCA. The 
process evaluation explored how the intervention worked and 
described and explained the variation in the organisational 
response to the intervention, in order to distil learning for 
future interventions. The findings from this component 
are reported elsewhere.9 This paper presents findings from 
the CCA, in which qualitative data were used to define 
the consequences and the level of engagement of each 
organisation with the intervention. We have chosen to have 
the consequences derived from the qualitative part of the 
evaluation in line with a mix-methods approach.
Board meetings attended by the research team were held in 
public, and organisations were informed of the presence of 
the research team, and this research, beforehand.
Sampling Criteria
A letter inviting hospital-sector organisations to participate in 
the intervention was sent to one of the executive directors of 
9 healthcare organisations in a network of providers in a large 
urban area. These 9 organisations were selected due to their 
geographical location, as attendance to the workshops was a 
mandatory component of the intervention. Six organisations 
(5 acute care providers and 1 mental health provider) agreed 
to participate (the ‘participating organisations’). In England, 
healthcare provider organisations may incorporate more than 
1 hospital, overseen by a single corporate board. Our study 
focused on organisations as the unit of analysis, and not 
individual hospitals. Data were also collected from a comparator 
group (‘comparator organisations’) of 6 organisations which 
individually matched each of those in the intervention group 
on the following dimensions: type of service provided (acute, 
community or mental health), foundation trust status[1], 
performance (as assessed by the English healthcare regulator) 
and number and location of sites. We also selected an 
additional 3 organisations as benchmarks to reflect different 
performance levels (‘outstanding,’ ‘good’ and ‘requires 
improvement’ as rated by the English healthcare regulator, 
the Care Quality Commission, CQC), giving a total of 15 
organisations. There were, therefore, three different groups of 
organisations: (1) those that participated in the intervention, 
named participating or intervention organisations (n = 
6); (2) those matched to the participating organisations for 
comparison, called comparator organisations (n = 6) and (3) 
the benchmark organisations, which are compared to both 
the intervention and comparator organisations. Figure 2 show 
the possible comparisons.
Figure 2. Participating Organisations, Comparators and Benchmarks. Abbreviation: CQC, Care Quality Commission.
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Data Collection
Data were collected across 4 phases in all 15 organisations, 
and grouped into 3 time-periods – ‘before’ the intervention 
(March 2014–June 2014), ‘during’ the intervention (July 2014–
April 2015) and ‘after’ the intervention (May 2015–November 
2016). Interviews were undertaken with board members (4 to 
6 per organisation) in the 6 organisations that had agreed to 
participate in the evaluation and in one comparator and one 
benchmark organisation which volunteered to take part in 
the interviews (interviews were not requested with the other 
organisations). In total, 37 interviews were carried out in 2014 
and 28 in 2015/2016. We asked boards to nominate members, 
both executive and non-executive directors, including the 
non-executive director responsible for quality. Interviews 
were semi-structured and covered topics in relation to the 
governance of QI (Supplementary file 3). We also observed 
the public part of the board meeting on 2 occasions for all 
15 organisations. In sum, we observed 60 hours of board 
meetings taking notes of quality-related discussions, who 
raised and discussed these issues, which of the 8 QUASER 
challenges they related to, time spent discussing quality 
and how quality-related issues were considered within 
each organisation. In addition, we collated relevant QI 
documentation. We used publicly available documents for 
the comparator and benchmark organisations and asked 
the 6 participating organisations to provide documents that 
most closely described their approach to QI. A range of other 
publicly available documents were also collected for analysis 
including: Quality Accounts[2] for the last year; rolling 5-year 
strategy; board of directors’ minutes and other board meeting 
papers; Quality committee meeting minutes for the previous 3 
months; CQC documents; and, any other relevant documents 
provided by the participating organisations. 
Cost-Consequences Analysis
We undertook a CCA of the iQUASER intervention. This is a 
form of economic evaluation comparing alternative options 
in which the components of incremental costs (direct or 
indirect) and consequences (eg, knowledge, behaviours, and 
processes) are computed and listed, without aggregating the 
results into a cost-effectiveness ratio. This form of economic 
evaluation is distinct from both cost-effectiveness analysis and 
cost-benefit analysis, which tend to focus on a single outcome 
measure and aggregate costs and the outcome into a single 
summary measure.12,13 The CCA is the appropriate form of 
economic analysis to use in the present study given the range 
of possible outcome measures for the iQUASER intervention. 
Measuring Consequences
In total, 6 quantifiable outcome measures were included, 
based on the literature and discussions within the team and 
with our FP partners10,15-18 (Table 1).
Developing and assigning the ratings for each outcome 
was an iterative, interpretive process that drew on qualitative 
data (interview accounts, observations of board meetings and 
documents), as well as team discussion. Initially members 
of the research team (LP, NF, JA, GR, SB) were assigned 3 
organisations each to independently score them for each of 
the 6 measures described above based on a review of board 
minutes, board observations and quality documents. This 
Table 1. Scale and Criteria for Measuring Consequences
Measure Consequence Scale
C1 Organisation-wide strategy 
1.	 Very fragmented
2.	 Moderately fragmented
3.	 Managed internally
4.	 One overall QI strategy
C2 Extent of addressing each of the 8 challenges 
1.	 No evidence of awareness
2.	 Planning 
3.	 Doing
4.	 Evaluating an action undertaken
5.	 Revision and wider learning
C3 Comparison with 'benchmark' Trust 
1.	 Not very similar to the benchmark
2.	 Similar to a small extent 
3.	 Similar to a moderate extent 
4.	 Similar to a large extent
C4 Comparison with high performing 'benchmark' Trust 
1.	 Not very similar 
2.	 Similar to a small extent
3.	 Similar to a moderate extent
4.	 Similar to a large extent
C5 Engagement with the intervention 
1.	 Minimal 
2.	 Moderate
3.	 Strong
C6 Implementation 
1.	 Not at all 
2.	 To a little extent 
3.	 To a moderate extent 
4.	 To a great extent
Abbreviation: QI, quality improvement.
Note: For high-performing participating and comparator organisations, C3 and C4 were effectively the same because only one outstanding benchmark Trust 
was recruited (See Supplementary file 1, Tables S2 and S3).
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initial process was carried out before September 2015 to 
ensure the ‘before’ ratings were unbiased. The research team 
then came together to discuss the initial ratings and agree on 
the definitions of the rating criteria. Once the definitions had 
been agreed, LP reviewed all ratings. The team met once again 
and agreed final scores (after September 2015). This process 
was repeated for every organisation and for each of the 6 
attributes described below. 
Organisation-Wide Strategy (C1)
In order to assess the existence or development of an 
organisation-wide strategy (labelled consequence C1), we 
asked all participating organisations to provide us with 
the documents that represented their QI strategy and we 
triangulated these with documents previously collected 
(quality accounts, quality committee minutes, board meeting 
papers). 
Addressing the QUASER 8 Challenges (C2)
To assess the extent to which organisations had jointly met 
each of the 8 challenges (labelled consequence C2), we 
analysed board meeting observations, minutes and the quality 
accounts ‘before’ and ‘after’ the intervention. We used the 
‘quality cycle’18 to understand where in the QI journey each 
organisation was before and after the intervention, creating 
a 5-point scale (see Table 1, C2). For example, a healthcare 
organisation might be ‘planning’ to address the cultural 
challenge but had not yet done so; another organisation 
might have planned and carried out actions in relation to the 
physical challenge, and so forth.
Comparison With “Benchmark” Organisations
We wanted to understand how participating and comparator 
organisations compared to benchmarks. Therefore, a rating 
of how each intervention and comparator organisations 
compared with a ‘benchmark’ organisation was assigned 
based on documents and board observations and using 
the above consequences (C1, C2). Figure 2 shows the 
possible comparisons between organisations. While there 
were 3 benchmark organisations, we defined 2 different 
benchmarks comparisons: one that had been rated by the 
English healthcare regulator at an equivalent CQC level (this 
comparison was labelled consequence C3) or comparison 
with a high-performing ‘outstanding CQC rated’ benchmark 
(labelled consequence C4). Assessment of each (participating 
and comparator) organisation in relation to benchmark 
organisations was also based on a 4-point scale, defined as 
(1) not very similar to the benchmark, (2) similar to a small 
extent, (3) similar to a moderate extent, and (4) similar to 
a large extent. Intervention and comparator organisations 
were considered very similar to the benchmark based on 
how they compared in terms of their ratings for C1 and C2. 
We assumed that becoming more similar to the benchmark 
is an improvement, that is, a higher score in the scale in the 
after period is an improvement. This is an assumption, and 
while it seems logic particularly for the comparison with the 
‘outstanding CQC rated’ benchmark, it could be argued that 
it is a deterioration when comparing to the ‘inadequate CQC 
rated’ benchmark. For consistency, we have always assumed 
that the more similar an organisation is to the benchmarks, 
the better. Assessments were made before and after the 
iQUASER intervention (March 2014/June 2014 and May 
2015/November 2016, respectively). If an organisation had 
improved in C3 or C4 over time, this effectively meant that it 
had become more similar to the benchmark.
Engagement (C5)
Engagement with the intervention (minimal, moderate and 
strong) was assessed on the basis of attendance at workshop/
action learning sets, consistency of participants, seniority of 
participants.
Implementation of an Organisation-Wide QI Project (C6)
Finally, assessment of the extent of implementation of the 
proposed organisation-wide QI project selected to be carried 
out during the iQUASER intervention was based on interviews 
with implementation leads immediately after the second 
learning set, and at the 12 months follow up, and relevant 
documents (board meeting papers, annual reports, slide 
packs). Implementation was rated according to the following 
scale: (1) none (eg, no actions had been taken); (2) to a little 
extent (eg, evidence of continued discussion and planning); 
(3) to a moderate extent (eg, evidence of some action); (4) to 
a great extent (eg, evidence of implementation). 
Local Context During the Time of the Intervention
The iQUASER intervention took place between July 2014 
and April 2015. Considering that part of the evaluation was 
conducted before and after the intervention period, one 
could expand the time relevant to the intervention to fiscal 
years 2014/2015 and 2015/2016. These 2 fiscal years coincide 
exactly with the beginning of the coalition government, 
which according to the King’s Fund found additional funding 
in 2014/2015, both new, but mostly reallocated from within 
existing budgets, to support direct patient care within the 
NHS. The coalition government had also announced plans 
to increase the NHS budget by more than £3 billion in cash 
terms in 2015/2016, which was perceived as a change in 
the austerity trend that had imposed NHS salaries freeze in 
2010/2011. Having said that, looking back retrospectively, it 
is understood that the NHS has been under severe financial 
pressure since 2010/2011 and that the coalition measures 
of 2014/2015 and 2015/2016 did not alleviate the austerity 
climate within the healthcare service.
Measuring Costs
We identified 7 cost components: (a) sign up to the intervention 
(upfront cost); (b) project engagement and presentation; 
(c) completion of self-assessment tool; (d) workshop; (e) 
team discussion; (f) follow up action learning sets; and (g) 
costs of activities and actions to meet workshop objectives. 
Although it was expected that iQUASER could result in 
an increase in the number of actions and interventions to 
improve health outcomes or reduce harm, we have explicitly 
chosen not to include the costs of these consequent actions 
and interventions, as these were downstream outputs and 
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potential cost savings, which would be too diffuse to identify.
All costs were valued in monetary terms. These included 
(1) financial outlays that were incurred directly as a result of 
the iQUASER intervention, and (2) time costs incurred by 
staff participating in the intervention, which were valued in 
money terms using market prices from published unit costs.19 
We took an NHS perspective, which meant we also included 
costs that were not borne by the participating organisations 
but would have been incurred by the NHS, eg, developing and 
delivering iQUASER and venue hire. 
All costs refer to direct or opportunity costs incurred 
between the point of project sign up (July 2014) and the last 
learning set of the intervention (April 2015). For the time 
cost components, the research team, who were present at the 
presentation and discussion meetings, workshop and action 
learning sets, directly observed actual time spent on each 
activity (b-f). For cost component (g), an estimate of time was 
directly asked to participating organisations, and included 
only staff costs. All costs were measured in Great British 
Pounds (£) of 2015/2016.
Results
Implementation of an Organisation-Wide QI Project 
Following the intervention, 2 of the 6 participating 
organisations appointed a director of QI who was 
responsible for producing an organisation-wide QI strategy, 
and to instigate and coordinate QI activities across their 
organisations. These 2 organisations also implemented an 
organisation-wide QI project as intended (Organisation 6 
set up an organisation-wide QI facility and organisation 5 
implemented an organisation wide QI project for patients with 
diabetes). Organisation 5 did not produce an organisation-
wide QI strategy but did implement a range of QI projects 
(a review of QI governance, introducing a smoking ban, 
and reducing the number of patients awaiting a bed and 
non-clinical transfers). The remaining organisations did not 
produce an organisation-wide QI strategy or implement an 
organisation wide QI project. 
Engagement and Organisation-Wide Strategy
There appeared to be a positive relationship between the 
level of engagement with iQUASER, the development 
of an organisation-wide QI strategy, and the degree 
of implementation of a QI project. Table 2 shows that 
organisations that engaged moderately or strongly with the 
intervention were also the ones to improve in the development 
of an organisation-wide QI strategy. Only organisations that 
strongly engaged with iQUASER also implemented their 
proposed QI project to a large extent, whereas the ones that 
engaged minimally did not implement their proposed project.
In other words, the 3 organisations that went on to 
implement an organisation-wide QI project, to some degree, 
following the intervention were more highly engaged with the 
intervention (as reflected in the consistency of participation, 
the seniority of board members who participated, and support 
from the Board for the intervention) than the 3 organisations 
that did not implement a QI project. 
Our findings also suggest that support from the board, 
especially the chief executive officer (CEO) and chair, for 
participation in the intervention, was related to engagement 
with the intervention. For example, in Organisation 6, the 
CEO showed strong support for the intervention, attending 
all sessions (see Supplementary file 1, Table S1). In contrast, 
in Organisation 4, participation in the intervention was not 
supported by the board, indeed the chair was actively hostile 
to the intervention. 
Improvements in Consequences C1-C4
Table 3 presents the results in terms of improvement in each 
outcome for participating and comparator organisations. 
Improvement was measured by comparing ratings before and 
after the iQUASER intervention. For organisation-wide QI 
Table 2. Level of Engagement and Degree of Implementation of the Intervention (Participating Organisations Only)
Level of Engagement Organisation-Wide QI Strategy Improvement Degree of Implementation of QI Project
Organisation 1 Minimal Not improved Not at all
Organisation 2 Minimal Not improved Not at all
Organisation 3 Moderate Improved Moderate extent
Organisation 4 Moderate Improved Not at all
Organisation 5 Strong Improved Large Extent
Organisation 6 Strong Improved Large Extent
Abbreviation: QI, quality improvement.
Table 3. Number of Organisations That Have Achieved an Improvement in Consequences (Before and After Improvement) – Participating and Comparators
Consequences Participating Organisations Comparator Organisations
Organisation-wide strategy (C1) 4 2 
Extent of addressing each challenge (C2) 1 0 
Comparison with ‘equally CQC rated benchmark' (C3) 4 2
Comparison with high-performing benchmark  (C4) 6 2 
Note: Tables S2 and S3 in Supplementary file 1 show the results for each organisation (participating, comparators and benchmarks) before and after the 
intervention respectively.
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strategy (C1), healthcare organisations that participated in 
iQUASER improved in the development of an organisation-
wide strategy more than comparator organisations, that 
is, 4 of the total 6 participating organisations achieved an 
improvement, while only 2 out of 6 comparator organisations 
improved by one point or more. Addressing each of the 8 
challenges (C2) was the consequence with the least observed 
improvement, with only one participating organisation 
improving by one or more points in the 5-point scale and no 
comparator organisation improving.
More intervention organisations became more similar 
to their own CQC-rated benchmark (C3) than comparator 
organisations, with 4 of the total 6 participating organisations 
achieving an improvement, compared to only 2 out of 6 
comparator organisations. Finally, all organisations that 
participated in iQUASER became more similar to the high-
performing benchmark (C4), while only 2 comparator 
organisations moved towards this benchmark. 
As the level of engagement with the intervention and 
improvements in the development of a QI strategy move 
in the same direction, we have chosen to look at the 
consequences by level of engagement. Table 4 presents the 
number of organisations (participating and comparators), 
where an improvement was observed after the intervention 
for consequences 1 to 4 (C1–C4), by level of engagement.
We found that organisations that engaged strongly or 
moderately with the intervention improved by at least 
one point in the scale in terms of the development of an 
organisation-wide strategy (C1), whilst for those that 
only engaged minimally no improvement was observed. 
Comparator organisations matched to those that engaged 
moderately or strongly were less likely to achieve an 
improvement, with only 1 out of 6 actually improving by 1 
point or more. Nonetheless, whilst no minimally engaged 
participating organisation improved in consequence one, one 
of the matched comparators has achieved an improvement in 
terms of the development of an organisation-wide QI strategy.
In relation to the extent of addressing each of the 8 challenges 
(C2), in the participating group, only one organisation which 
strongly engaged with the intervention improved by one point 
or more. None of the comparator organisations improved by 
one point or more in this consequence. 
Thirdly, we compared the intervention and comparison 
organisations to the ‘benchmarks’: whilst all participating 
organisations became more similar to the high-performing 
‘benchmark’ (C4) regardless of their level of engagement with 
the intervention, the same was not observed when comparing 
to their own CQC-level benchmark (C3). In the latter case, 
moderately engaged organisations have not become more 
similar to their benchmark. This could be because the 3 
benchmarks had not improved their own performance. 
In fact, the high-performing benchmark organisation had 
decreased its performance in terms of addressing each of the 8 
challenges, which may explain why participating organisations 
became more similar to this benchmark (C4). Finally, results 
show that fewer of the comparator organisations became 
more similar to their own CQC level benchmark (C3) and the 
high-performing one (C4), when compared to intervention 
organisations. In fact, only 2 out of 6 organisations have 
improved by one point in the defined scale in either case.
Cost Analysis
Table 5 presents the costs associated with the iQUASER 
intervention; the mean total cost per participating organisation 
was £23 496. The most costly component of the intervention 
was the workshop, which included the costs of developing 
and delivering the workshop itself and the staff time costs of 
having 3 to 5 board members attending a full day of activities. 
The second most costly component was the up-front cost of 
signing up to iQUASER. The third most costly component 
were the activities and actions to meet workshop objectives. 
This last component produced the greatest variation amongst 
participating organisations.
An analysis of costs by level of engagement found that a 
higher level of engagement was associated with higher costs 
of project engagement and presentation, completing the 
self-assessment tool and, to a minor extent, participating in 
the follow up learning sets. The opposite was observed with 
regards to team discussion, component for which stronger 
engagement is associated with lower costs. Finally, whilst 
minimally engaged organisations appear to have a significantly 
lower overall cost, both moderately and strongly engaged 
organisations have a higher average cost when compared to 
the overall mean.
Discussion
We have carried out an analysis of costs and consequences 
of a board level intervention to develop organisation-wide 
QI strategies in 15 hospitals in England. Our findings are 
consistent with those of the process evaluation, which found 
Table 4. Number of Organisations That Have Achieved an Improvement, by Level of Engagement
Consequence Trust Type Number of Organisations
Organisation-Wide 
Strategy (C1)
Extent of Addressing 
Each Challenge (C2)
Comparison With 
Benchmark Trust (C3)
Comparison With High-Performing 
Benchmark Trust (C4)
Strongly 
engaged
Participating 2 2 1 2 2 
Comparator 2 0 0 0 0 
Moderately 
engaged
Participating 2 2 0 0 2 
Comparator 2 0 0 1 1 
Minimally 
engaged
Participating 2 0 0 2 2 
Comparator 2 1 0 1 1 
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that organisational response was contingent on the level 
of engagement from the CEO and Chair, organisational 
‘readiness,’ and the availability of ‘slack.’9
The cost consequence analysis has shown that organisations 
which moderately or strongly engaged with the intervention 
were more likely to have achieved an improvement in the 
development of an organisation-wide QI strategy and 
implemented their chosen QI project to a greater extent than 
less strongly engaged organisations. The level of engagement 
was defined by the attendance at workshop/action learning 
sets, consistency of participants, seniority of participants. 
This relationship between engagement in the intervention 
and implementation of an organisation-wide QI project could 
be interpreted as evidence that board-level interventions 
may facilitate organisation-wide QI. Support from the 
board, especially from the Chair and CEO for participation 
in the intervention, appeared to be particularly important. 
This supports other findings that commitment from senior 
management is fundamental in supporting organisational 
‘absorptive capacity’ ie, the capacity to acquire, assimilate and 
apply knowledge to improve performance.20 
Further, the finding that all organisations which participated 
in iQUASER became more similar to the high-performing 
benchmark organisation seems to suggest that board-level 
interventions, such as iQUASER, are one possibility for 
improving overall performance. This is in line with findings 
of the Leadership Saves Lives study,21 which also found that 
“authentic” participation from staff in QI initiatives was 
linked to substantial culture change. Other studies have also 
found that support from senior leadership is important even 
in other sectors, such as nursing and care homes.22,23
However, our findings also have shown that minimally 
engaged organisations have also become more similar to 
the high-performing benchmark. Furthermore, a range of 
other QI initiatives took place in NHS organisations during 
the intervention time-period, including in the selected 
comparators, potentially confounding some of the results 
pointed out in our analysis. Therefore, our findings should be 
interpreted with care.
Regarding the extent of addressing all 8 QUASER challenges, 
only one organisation achieved an improvement. This may 
reflect the difficulty in obtaining a multi-faceted improvement, 
or that organisations were attending to challenges according 
to the priorities at the time. Other possible explanations could 
be that the methods we used were unable to consistently detect 
changes regarding this consequence, or that organisations have 
prioritised developing a QI strategy rather than specifically 
addressing the QUASER challenges.
By considering staff time (opportunity) costs, we were 
able to estimate the cost of the intervention, which to our 
knowledge has rarely (if at all) been studied in the QI literature. 
The iQUASER intervention was relatively inexpensive as 
a proportion of total healthcare provider organisation’s 
yearly budgets. Finally, staff time costs were a relatively high 
proportion of the total costs. Thus, there may be a trade-off 
in terms of opportunity cost and capacity to benefit from the 
intervention, that is, for the intervention to be most beneficial, 
organisations may need to have capacity or ‘slack’ to engage.9
Although relatively inexpensive, iQUASER did not result in 
much improvement for the organisations that only minimally 
engaged with the intervention, raising questions about resource 
usage. It is not unusual for NHS organisations to invest in QI 
initiatives, but not devote the time and effort necessary to 
achieve a more substantive results.2 The relationship between 
level of engagement and costs can be partly explained by staff 
time inputs, as organisations that engaged more strongly with 
the intervention either devoted more of their time or involved 
more senior board members. In terms of time, the minimally 
engaged organisations devoted more than 20% less time to 
participating and obtaining outputs from iQUASER. 
This analysis was innovative in that it has compiled both 
costs and consequences of a board-level QI intervention. 
One of the strengths of this analysis was that it performed 
several types of comparisons, including a direct comparison 
between intervention and comparator organisations, and 
the comparison of both intervention and comparator 
Table 5. Average Costs of the iQUASER Intervention Per Organisation, by Level of Engagement (in 2014/2015 UK Pounds)
Component of Intervention Strongly Engaged 
Moderately 
Engaged 
Minimally 
Engaged 
Overall 
Mean
% Of Total 
Cost
Sign up (upfront cost) £5000 £5000 £5000 £5000 21.3%
Project engagement and presentation £1175 £810 £960 £982 4.2%
Completing self-assessment £1215 £1018 £828 £1021 4.3%
Workshop £11 897 £11 104 £11 538 £11 513 49.0%
Team discussion £219 £323 £537 £360 1.5%
Follow up learning sets £2080 £1536 £1536 £1717 7.3%
Activities and actions to meet workshop objectives £2604 £5239 £868 £2904 12.4%
Total £24 190 £25 029 £21 267 £23 496 100%
Total staff time across all components combined (in hours) 87.8 92.5 64.5 81.6 -
Monetised staff time costs across all components combined as a proportion of total 
costs 
45.4% 47.2% 37.8% 43.7% -
Number of organisations 2 2 2 Total 6
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organisations with benchmarks in 2 different ways. 
Furthermore, the measured consequences were drawn from 
the qualitative analysis of iQUASER, making our analysis 
a true mixed-method study. The analysis of this paper was 
limited by the small number of participating healthcare 
provider organisations, by the lack of direct comparability 
between organisations, moderately overcome by the matched 
comparators. By using a mixed methods approach, we have 
effectively produced an analysis that uses both quantitative and 
qualitative measures. While we understand some subjectivity 
may rise from such approach, this is a common problem for 
organisational level interventions and our approach was to try 
and capture multiple aspects of the organisational response, 
which could inform other studies. In order to minimise 
this subjectivity, we studied QI using multiple data sources, 
triangulated to increase reliability, developed measures 
and cost estimates using robust procedures and included 
as an outcome the development of a QI project. While the 
findings from this study may not be directly transferable to 
other institutions, due to the small number of organisations 
participating on iQUASER, some of the general learnings, 
including the importance of the support of the Chair and 
CEO for the development of an organisation-wide QI strategy, 
may be applicable in a wider health care context. This is also 
similar with what other studies have found.20,22,23 As a result, 
one could consider that due to the relative inexpensive and 
effective nature of interventions such as iQUASER, policy-
makers and healthcare managers may feel inclined to fostering 
and promoting change in QI strategy development by means 
of this type of interventions. 
Conclusion
Evidence suggests that there is an association between board 
practices and the quality of care provided by the organisation.6,7 
However, few studies have demonstrated the impact of board-
level interventions on QI.6,7,9,24,25 To our knowledge, this is the 
first cost-consequence analysis of a board-level intervention 
like iQUASER. We have found there was a positive association 
between level of engagement with the intervention, 
development of an organisation-wide QI strategy and the 
implementation of a QI project. More of the participating 
healthcare organisations improved in the development of an 
organisation-wide QI strategy than comparator organisations. 
We have also found that all participating organisations 
became more similar to the high-performing ‘benchmark,’ 
while fewer of the comparator organisations became more 
similar to this benchmark. Finally, we found that iQUASER, 
a board-level intervention for QI, is relatively inexpensive as 
a proportion of total NHS healthcare organisations’ budgets. 
Although the evidence from this study is novel in that it not 
only considers consequences but also cost of a board-level QI 
intervention, more in-depth qualitative research is needed to 
fully understand our findings, particularly with regards to the 
mechanisms behind the improvements observed, which have 
been analysed elsewhere.9 Further work should also focus 
on more downstream process markers that might link to 
outcome measures, and explore the links between board-level 
interventions and these markers.
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Endnotes
[1] NHS Foundation Trusts are semi-autonomous organisations that operate 
within the NHS in England, They have been described in detail by  Robinson,3 
Walshe,4  Verzulli et al.5
[2] Quality account is a report about the quality of services provided by a NHS 
healthcare organisation. For more information about quality accounts, see 
https://www.nhs.uk/using-the-nhs/about-the-nhs/quality-accounts/.
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